Genitourinary Syndrome of Menopause: New Terminology for Vulvovaginal Atrophy from the International Society for the Study of Women's Sexual Health and The North American Menopause Society

被引:72
|
作者
Portman, David J. [1 ]
Gass, Margery L. S. [2 ]
机构
[1] Columbus Ctr Womens Hlth Res, Columbus, OH 43213 USA
[2] North Amer Menopause Soc, Mayfield Hts, OH USA
来源
JOURNAL OF SEXUAL MEDICINE | 2014年 / 11卷 / 12期
关键词
Atrophic Vaginitis; Genitourinary Syndrome of Menopause; Menopause; Urinary Urgency; Vulvovaginal Atrophy; Women's Sexual Health; POSTMENOPAUSAL WOMEN; UROGENITAL SYMPTOMS; TREATMENT OPTIONS; DYSFUNCTION; IMPACT; PREVALENCE; DIAGNOSIS; DEFINITION; MANAGEMENT; COMMITTEE;
D O I
10.1111/jsm.12686
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
IntroductionThe terminology for the genitourinary tract symptoms related to menopause was vulvovaginal atrophy, which does not accurately describe the symptoms nor is a term that resonates well with patients. AimIn 2012, the Board of Directors of the International Society for the Study of Women's Sexual Health (ISSWSH) and the Board of Trustees of The North American Menopause Society (NAMS) acknowledged the need to review current terminology associated with genitourinary tract symptoms related to menopause. MethodsThe two societies cosponsored a terminology consensus conference, which was held in May 2013. Main Outcome MeasureThe development of a new terminology that more accurately described the genitourinary tract symptoms related to menopause. ResultsMembers of the consensus conference agreed that the term genitourinary syndrome of menopause (GSM) is a medically more accurate, all-encompassing, and publicly acceptable term than vulvovaginal atrophy. GSM is defined as a collection of symptoms and signs associated with a decrease in estrogen and other sex steroids involving changes to the labia majora/minora, clitoris, vestibule/introitus, vagina, urethra, and bladder. The syndrome may include but is not limited to genital symptoms of dryness, burning, and irritation; sexual symptoms of lack of lubrication, discomfort or pain, and impaired function; and urinary symptoms of urgency, dysuria, and recurrent urinary tract infections. Women may present with some or all of the signs and symptoms, which must be bothersome and should not be better accounted for by another diagnosis. ConclusionThe term GSM was presented and discussed at the annual meeting of each society. The respective Boards of NAMS and ISSWSH formally endorsed the new terminologygenitourinary syndrome of menopausein 2014. DJ Portman, MLS Gass, on behalf of the Vulvovaginal Atrophy Terminology Consensus Conference Panel. Genitourinary syndrome of menopause: New terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and The North American Menopause Society. J Sex Med 2014;11:2865-2872.
引用
收藏
页码:2865 / 2872
页数:8
相关论文
共 50 条
  • [1] Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and The North American Menopause Society
    Portman, David J.
    Gass, Margery L. S.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2014, 21 (10): : 1063 - 1068
  • [2] Genitourinary syndrome of menopause: New terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and The North American Menopause Society
    Portman, D. J.
    Gass, M. L. S.
    MATURITAS, 2014, 79 (03) : 349 - 354
  • [3] Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and The North American Menopause Society
    Portman, D. J.
    Gass, M. L. S.
    CLIMACTERIC, 2014, 17 (05) : 557 - 563
  • [4] Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women's Sexual Health
    Faubion, Stephanie S.
    Larkin, Lisa C.
    Stuenkel, Cynthia A.
    Bachmann, Gloria A.
    Chism, Lisa A.
    Kagan, Risa
    Kaunitz, Andrew M.
    Krychman, Michael L.
    Parish, Sharon J.
    Partridge, Ann H.
    Pinkerton, JoAnn V.
    Rowen, Tami S.
    Shapiro, Marla
    Simon, James A.
    Goldfarb, Shari B.
    Kingsberg, Sheryl A.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2018, 25 (06): : 596 - 608
  • [5] The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society
    不详
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2020, 27 (09): : 976 - 992
  • [6] Highlights From the 2020 Genitourinary Syndrome of Menopause Position Statement of The North American Menopause Society
    Faubion, Stephanie S.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2020, 27 (12): : 1452 - 1452
  • [7] From vulvovaginal atrophy to the genitourinary syndrome of menopause: what's in a name?
    Shifren, Jan
    GYNECOLOGICAL ENDOCRINOLOGY, 2016, 32 : 36 - 36
  • [8] Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2013, 20 (09): : 888 - 902
  • [9] The role of androgens in the treatment of genitourinary syndrome of menopause (GSM): International Society for the Study of Women's Sexual Health (ISSWSH) expert consensus panel review
    Simon, James A.
    Goldstein, Irwin
    Kim, Noel N.
    Davis, Susan R.
    Kellogg-Spadt, Susan
    Lowenstein, Lior
    Pinkerton, JoAnn V.
    Stuenkel, Cynthia A.
    Traish, Abdulmaged M.
    Archer, David F.
    Bachmann, Gloria
    Goldstein, Andrew T.
    Nappi, Rossella E.
    Vignozzi, Linda
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2018, 25 (07): : 837 - 847
  • [10] The view of the International Menopause Society on the Women's Health Initiative
    Schneider, HPG
    CLIMACTERIC, 2002, 5 (03) : 211 - 216